NZ611947A - Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors - Google Patents
Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumorsInfo
- Publication number
- NZ611947A NZ611947A NZ611947A NZ61194707A NZ611947A NZ 611947 A NZ611947 A NZ 611947A NZ 611947 A NZ611947 A NZ 611947A NZ 61194707 A NZ61194707 A NZ 61194707A NZ 611947 A NZ611947 A NZ 611947A
- Authority
- NZ
- New Zealand
- Prior art keywords
- plus
- corticosteroid
- treating tumors
- corticosteroids
- corticosteroid chemotherapeutic
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200601232 | 2006-09-26 | ||
NZ59735707 | 2007-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ611947A true NZ611947A (en) | 2015-01-30 |
Family
ID=52464885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ611947A NZ611947A (en) | 2006-09-26 | 2007-09-26 | Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ611947A (en) |
-
2007
- 2007-09-26 NZ NZ611947A patent/NZ611947A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ576122A (en) | Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors | |
MX2007003795A (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases. | |
NZ604029A (en) | Methods of treating bladder cancer | |
MY151449A (en) | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 | |
MX2010003815A (en) | Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent. | |
BRPI0906181A2 (en) | "method for treating hyperproliferative dysfunction, pharmaceutical composition, use of a therapeutic combination in the manufacture of a medicament for treating cancer, article of manufacture for treating a hyperproliferative dysfunction, method for determining compounds to be used in combination for the treatment of cancer". cancer treatment and method for determining a therapeutic combination to be used for cancer treatment " | |
HK1123186A1 (en) | Combination of zd6474 and pemetrexed zd6474 | |
MX2007003505A (en) | Combination comprising zd6474 and an imatinib. | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
MX353964B (en) | Therapeutic agents and uses thereof. | |
MX2011013424A (en) | Method of treating cancer with dll4 antagonist and chemotherapeutic agent. | |
HK1123976A1 (en) | Combination of azd2171 and pemetrexed azd2171 | |
HK1096023A1 (en) | Combination therapy with azd2171 and 5-fu and/or cpt-11 azd2171?5-fu?cpt-11 | |
MXPA05008583A (en) | Combination therapy of zd6474 with 5-fu or/and cpt-11. | |
IL177953A0 (en) | Combination therapy including azd2171 and a taxane | |
WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine | |
MX2018015916A (en) | Porphyrin compounds and compositions useful for treating cancer. | |
NZ611947A (en) | Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors | |
IL307842A (en) | Methods and compositions for treating glioblastoma | |
NZ602407A (en) | Cd37 immunotherapeutic combination therapies and uses thereof | |
UA95797C2 (en) | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 | |
WO2009140572A3 (en) | Combinatorial treatment with glucose regulated protein-170 and melanoma differentiation associated gene-7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 26 SEP 2017 BY WATERMARK PATENT AND TRADE MARKS ATTORNEYS Effective date: 20150505 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2018 BY CPA GLOBAL Effective date: 20170810 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2019 BY CPA GLOBAL Effective date: 20180809 |
|
S38C | Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended | ||
S38C | Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2020 BY CPA GLOBAL Effective date: 20190815 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY CPA GLOBAL Effective date: 20200813 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY CPA GLOBAL Effective date: 20210812 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY CPA GLOBAL Effective date: 20220811 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY CPA GLOBAL Effective date: 20230811 |